tiprankstipranks
Trending News
More News >
Hoth Therapeutics Inc (HOTH)
NASDAQ:HOTH
US Market

Hoth Therapeutics (HOTH) Income Statement

Compare
399 Followers

Hoth Therapeutics Income Statement

Last quarter (Q3 2024), Hoth Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Hoth Therapeutics's net income was $-2.13M. See Hoth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -66.83K$ -46.87M$ -25.87K
Operating Expenses
$ 8.22M$ 7.69M$ 11.07M$ 14.10M$ 7.30M
Depreciation and Amortization
$ 0.00$ 7.69M$ 11.07M$ 1.04K$ 1.04K
EBITDA
$ -8.22M$ -153.15K$ 0.00$ -14.10M$ -7.30M
Operating Income
$ -8.22M$ -7.69M$ -11.07M$ -14.10M$ -7.30M
Other Income/Expenses
$ 27.13K$ -153.15K$ -306.40K$ -212.26K$ 104.16K
Pretax Income
$ -8.19M$ -7.85M$ -11.37M$ -14.31M$ -7.20M
Net Income
$ -8.19M$ -7.85M$ -11.68M$ -14.31M$ -7.20M
Per Share Metrics
Basic EPS
$ -1.28$ -2.30$ -9.75$ -16.03$ -14.56
Diluted EPS
$ -1.28$ -2.30$ -9.75$ -16.03$ -14.56
Weighted Average Shares Outstanding
6.38M 3.41M 1.20M 893.20K 494.51K
Weighted Average Shares Outstanding (Diluted)
6.38M 3.41M 1.20M 893.20K 494.51K
Currency in USD

Hoth Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis